Biogen Pharmachem Industries Ltd Q2 FY2024-2025 Results: Summary

Revenue
₹0.65Cr
Net Profits
₹-1Cr
Net Profit Margins
153.85%

Highlights

Revenue:

Biogen Pharmachem Industries Ltd’s revenue fell -185.53% since last year same period to ₹0.65Cr in the Q2 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -622.22% fall in its revenue since last 3-months.

Net Profits:

Biogen Pharmachem Industries Ltd’s net profit fell -238.89% since last year same period to ₹-1Cr in the Q2 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -525% fall in its net profits since last 3-months.

Net Profit Margins:

Biogen Pharmachem Industries Ltd’s net profit margin jumped 62.39% since last year same period to 153.85% in the Q2 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -13.46% fall in its net profit margins since last 3-months.

FAQs

The revenue for Biogen Pharmachem Industries Ltd in the Q2 results 2024 was ₹0.65Cr.

The net profit for Biogen Pharmachem Industries Ltd in the Q2 results 2024 was ₹-1Cr.

The net profit margin for Biogen Pharmachem Industries Ltd in the Q2 results 2024 was 153.85%.

The revenue for Biogen Pharmachem Industries Ltd in the Q2 results 2023 was ₹0.76Cr.

The net profit for Biogen Pharmachem Industries Ltd in the Q2 results 2023 was ₹0.72Cr.

The net profit margin for Biogen Pharmachem Industries Ltd in the Q2 results 2023 was 94.74%.